• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

AJCC/TNM cancer staging, present and future.

作者信息

Fleming I D

出版信息

J Surg Oncol. 2001 Aug;77(4):233-6. doi: 10.1002/jso.1101.

DOI:10.1002/jso.1101
PMID:11473370
Abstract
摘要

相似文献

1
AJCC/TNM cancer staging, present and future.美国癌症联合委员会/国际抗癌联盟癌症分期体系的现状与未来
J Surg Oncol. 2001 Aug;77(4):233-6. doi: 10.1002/jso.1101.
2
TNM staging for malignancies of the digestive tract: 2003 changes and beyond.消化道恶性肿瘤的TNM分期：2003年的变化及后续发展
Semin Surg Oncol. 2003;21(1):23-9. doi: 10.1002/ssu.10018.
3
Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.评估澳大利亚新南威尔士癌症登记处的改良-AJCC TNM 分期系统。
BMC Cancer. 2019 Aug 28;19(1):850. doi: 10.1186/s12885-019-6062-x.
4
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.第八版泌尿生殖系统癌症肿瘤-淋巴结-转移分期分类更新。
Eur Urol. 2018 Apr;73(4):560-569. doi: 10.1016/j.eururo.2017.12.018. Epub 2018 Jan 9.
5
The future of the TNM staging system in laryngeal cancer: time for a debate?喉癌TNM分期系统的未来：是时候展开一场辩论了？
Eur Arch Otorhinolaryngol. 2008 Dec;265(12):1441-3. doi: 10.1007/s00405-008-0772-z. Epub 2008 Jul 22.
6
Comments on the editorial by Ferlito and Rinaldo: "The future of TNM staging system in laryngeal cancer: time for a debate?".对费利托和里纳尔多社论的评论：“喉癌TNM分期系统的未来：是时候展开辩论了吗？”
Eur Arch Otorhinolaryngol. 2008 Dec;265(12):1445-6. doi: 10.1007/s00405-008-0771-0. Epub 2008 Jul 22.
7
Concerning the editorial "The future of the TNM staging system in laryngeal cancer: time for a debate?" by Ferlito and Rinaldo.关于费利托和里纳尔多撰写的社论《喉癌TNM分期系统的未来：是时候展开一场辩论了？》
Eur Arch Otorhinolaryngol. 2009 Jan;266(1):155; author reply 157-8. doi: 10.1007/s00405-008-0810-x. Epub 2008 Sep 20.
8
Authors' response to the comments by Eckel on the editorial "The future of the TNM staging system in laryngeal cancer: time for a debate?".作者对埃克尔就社论《喉癌TNM分期系统的未来：是时候展开辩论了？》所提评论的回应。
Eur Arch Otorhinolaryngol. 2009 Jan;266(1):153-4. doi: 10.1007/s00405-008-0811-9. Epub 2008 Sep 20.
9
A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.第 7 版和第 8 版 AJCC 分期系统在预测甲状腺乳头状癌患者复发和生存方面的比较。
Oral Oncol. 2018 Dec;87:158-164. doi: 10.1016/j.oraloncology.2018.11.003. Epub 2018 Nov 9.
10
Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.日本对AJCC/UICC TNM分期系统第八版用于人乳头瘤病毒介导的口咽癌的确认。
Int J Clin Oncol. 2017 Aug;22(4):682-689. doi: 10.1007/s10147-017-1107-0. Epub 2017 Mar 7.

引用本文的文献

1
Hepatocellular Carcinoma in South Indian Population: Clinical Profile and AFP Correlation with Radiological Tumor Size.南印度人群中的肝细胞癌：临床特征及甲胎蛋白与放射学肿瘤大小的相关性
J Pharm Bioallied Sci. 2025 Jun;17(Suppl 2):S1940-S1945. doi: 10.4103/jpbs.jpbs_1864_24. Epub 2025 Jun 18.
2
Evaluation of prognostic factors affecting survival in chondrosarcoma treatment and comparison with literature.评估影响软骨肉瘤治疗生存的预后因素并与文献比较。
Jt Dis Relat Surg. 2022;33(2):440-448. doi: 10.52312/jdrs.2022.526. Epub 2022 Jul 6.
3
Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis.
肿瘤-间质比在直肠癌中的预后价值：一项系统评价和Meta分析
Front Oncol. 2021 May 26;11:685570. doi: 10.3389/fonc.2021.685570. eCollection 2021.
4
The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma.MTH1和NUDT5的高表达预示着较差的生存率，且与食管鳞状细胞癌的恶性程度相关。
PeerJ. 2020 May 26;8:e9195. doi: 10.7717/peerj.9195. eCollection 2020.
5
Update on oral and oropharyngeal cancer staging - International perspectives.口腔和口咽癌分期的最新进展——国际视角
World J Otorhinolaryngol Head Neck Surg. 2020 Mar 6;6(1):66-75. doi: 10.1016/j.wjorl.2019.06.001. eCollection 2020 Mar.
6
Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.食管腺癌的医疗成本估算和预测因素：一项基于人群的队列研究。
BMC Cancer. 2018 Jun 27;18(1):694. doi: 10.1186/s12885-018-4620-2.
7
Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma.经动脉化疗栓塞术作为射频消融术的替代方法用于治疗巴塞罗那临床肝癌分期0/A期的肝细胞癌。
Oncotarget. 2018 Apr 20;9(30):21560-21568. doi: 10.18632/oncotarget.25108.
8
Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.社会经济地位对食管癌诊断分期、治疗接受情况及生存的影响：一项基于人群的队列研究。
PLoS One. 2017 Oct 11;12(10):e0186350. doi: 10.1371/journal.pone.0186350. eCollection 2017.
9
Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.现实环境中肝细胞癌非根治性或姑息性治疗的成本效益分析。
PLoS One. 2017 Oct 10;12(10):e0185198. doi: 10.1371/journal.pone.0185198. eCollection 2017.
10
Hepatocellular carcinoma: a review.肝细胞癌：综述
J Hepatocell Carcinoma. 2016 Oct 5;3:41-53. doi: 10.2147/JHC.S61146. eCollection 2016.